Neuphoria Therapeutics Inc.
NEUP
Rank in Stocks
#27582
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Share Price
$2.55
Last synced: 2026-11-13
Market Cap
$13.80M
Change (1 day)
-1.16%
Change (1 year)
-42.83%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Neuphoria Therapeutics Inc. (NEUP)
Category
Healthcare
EPS for Neuphoria Therapeutics Inc. (NEUP)
EPS as of June 2026 TTM: $-7.26
According to Neuphoria Therapeutics Inc.'s latest financial reports, its current EPS (TTM) is $-7.26. At the end of 2025 the company had an EPS of $-0.23, a decrease compared to its 2024 EPS of $-0.10.
EPS history for Neuphoria Therapeutics Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-7.26 | 3,056.52% |
| 2025 | $-0.23 | 130.00% |
| 2024 | $-0.10 | -37.46% |
| 2023 | $-0.16 | 15.95% |
| 2022 | $-0.14 | 83.87% |
| 2021 | $-0.08 | -1.19% |
| 2020 | $-0.08 | -32.47% |
| 2019 | $-0.11 | -67.01% |
| 2018 | $-0.34 | 240.36% |
| 2017 | $-0.10 | -59.28% |
| 2016 | $-0.25 | -13.72% |
| 2015 | $-0.28 | -470.00% |
| 2014 | $0.08 | -129.06% |
| 2013 | $-0.27 | 135.77% |
| 2012 | $-0.11 | -71.67% |
| 2011 | $-0.40 | 67.31% |
| 2010 | $-0.24 | 8.51% |
| 2009 | $-0.22 | -5.08% |
| 2008 | $-0.23 | -12.54% |
| 2007 | $-0.26 | 14.34% |
| 2006 | $-0.23 | -53.45% |
| 2005 | $-0.49 | 14.84% |
| 2004 | $-0.43 | -29.43% |
| 2003 | $-0.61 | 69.22% |
| 2002 | $-0.36 | 1.32% |
| 2001 | $-0.36 | -13.87% |
| 2000 | $-0.41 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -87.74% |
US
|
|
| $15.66 | -315.70% |
US
|
|
| $-7.07 | -2.62% |
US
|
|
| $-5.29 | -27.13% |
AU
|
|
| $12.73 | -275.37% |
BE
|
Questions about Neuphoria Therapeutics Inc.'s earnings per share (EPS)
What is Neuphoria Therapeutics Inc.'s earnings per share (EPS)?
Neuphoria Therapeutics Inc.'s earnings per share (EPS) over the last twelve months is $-7.26, as of Jun 2026.
What was Neuphoria Therapeutics Inc.'s earnings per share (EPS) in 2025?
In 2025, Neuphoria Therapeutics Inc.'s earnings per share (EPS) was $-0.23, compared with $-0.10 in 2024.
How has Neuphoria Therapeutics Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Neuphoria Therapeutics Inc.'s earnings per share (EPS) was highest in 2021 ($-0.08) and lowest in 2025 ($-0.23).
How does Neuphoria Therapeutics Inc.'s earnings per share (EPS) compare with similar companies?
Neuphoria Therapeutics Inc.'s earnings per share (EPS) ($-7.26) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.